HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas E Witzig Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2021Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia.
1/2019Acalabrutinib for mantle cell lymphoma.
11/2018Prognostic and therapeutic significance of phosphorylated STAT3 and protein tyrosine phosphatase-6 in peripheral-T cell lymphoma.
11/2018Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements.
1/2018MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia.
10/2017Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU).
5/2017Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
5/2017A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy.
9/2015A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402.
12/2014Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas E Witzig Research Topics

Disease

79Neoplasms (Cancer)
01/2022 - 02/2002
62Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2002
59Lymphoma (Lymphomas)
07/2022 - 01/2002
37Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 07/2007
35Multiple Myeloma
01/2021 - 11/2002
23Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2022 - 06/2002
18Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2021 - 05/2005
18Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021 - 01/2002
16B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2020 - 11/2002
13Disease Progression
01/2020 - 09/2002
12Immunoglobulin Light-chain Amyloidosis
06/2014 - 02/2003
10Infections
04/2021 - 06/2002
10Hodgkin Disease (Hodgkin's Disease)
01/2021 - 10/2005
10Thrombocytopenia (Thrombopenia)
08/2017 - 06/2002
9B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 01/2002
6Neutropenia
06/2020 - 01/2007
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 04/2003
5Colonic Neoplasms (Colon Cancer)
03/2007 - 09/2003
4Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 07/2006
4Fatigue
06/2020 - 04/2005
4Immunoglobulin G4-Related Disease
12/2018 - 06/2015
4Anemia
08/2017 - 01/2003
4Necrosis
01/2017 - 10/2003
4Smoldering Multiple Myeloma
01/2016 - 08/2004
4Paraproteinemias (Monoclonal Gammopathy)
12/2012 - 01/2002
4Autoimmune Diseases (Autoimmune Disease)
01/2011 - 09/2003
4Carcinoma (Carcinomatosis)
03/2007 - 05/2002
3Sepsis (Septicemia)
04/2021 - 06/2002
3Febrile Neutropenia
01/2020 - 07/2005
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018 - 09/2007
3T-Cell Lymphoma (Lymphoma, T Cell)
07/2015 - 10/2009
3Genetic Translocation (Chromosomal Translocation)
01/2015 - 09/2013
3POEMS Syndrome (Syndrome, POEMS)
07/2013 - 04/2003
3Chromosome Aberrations (Chromosome Abnormalities)
02/2011 - 05/2003
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
04/2008 - 06/2004

Drug/Important Bio-Agent (IBA)

50Rituximab (Mabthera)FDA Link
01/2021 - 01/2002
24Lenalidomide (CC 5013)FDA Link
01/2022 - 01/2007
21Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2003
20ibritumomab tiuxetan (Zevalin)FDA Link
07/2013 - 02/2002
16Dexamethasone (Maxidex)FDA LinkGeneric
11/2018 - 11/2002
12Pharmaceutical PreparationsIBA
01/2020 - 09/2002
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 08/2011
11TOR Serine-Threonine KinasesIBA
01/2019 - 08/2005
11EverolimusFDA Link
10/2018 - 07/2006
11CytokinesIBA
08/2017 - 08/2004
10Immunoglobulin M (IgM)IBA
01/2020 - 01/2002
10Monoclonal AntibodiesIBA
10/2008 - 08/2003
9Biomarkers (Surrogate Marker)IBA
07/2022 - 12/2006
8Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 12/2005
8Immunoglobulins (Immunoglobulin)IBA
11/2018 - 04/2006
8Thalidomide (Thalomid)FDA Link
10/2010 - 11/2002
7Prednisone (Sone)FDA LinkGeneric
01/2021 - 10/2011
7YttriumIBA
07/2013 - 02/2002
6ibrutinibIBA
10/2021 - 01/2017
6Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 12/2005
6Cyclin D1IBA
10/2020 - 08/2005
6Bortezomib (Velcade)FDA Link
01/2020 - 07/2005
6Mechanistic Target of Rapamycin Complex 1IBA
10/2018 - 10/2009
6temsirolimusFDA Link
04/2011 - 08/2005
6Yttrium-90IBA
10/2007 - 08/2002
5Methotrexate (Mexate)FDA LinkGeneric
07/2022 - 06/2004
5Biological ProductsIBA
10/2020 - 05/2002
5B-Cell Activating FactorIBA
05/2009 - 02/2006
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2006
4AnthracyclinesIBA
01/2021 - 08/2014
4Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019 - 07/2006
4LigandsIBA
01/2017 - 02/2008
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 08/2004
4Sirolimus (Rapamycin)FDA Link
03/2012 - 07/2006
4MTOR InhibitorsIBA
04/2011 - 10/2009
4CD20 AntigensIBA
03/2008 - 01/2006
3Bendamustine HydrochlorideFDA Link
01/2022 - 08/2018
3InterferonsIBA
01/2022 - 09/2012
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2021 - 03/2007
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 06/2002
3TroponinIBA
01/2019 - 09/2004
3SteroidsIBA
12/2018 - 03/2008
3Immunoglobulin G (IgG)IBA
04/2016 - 03/2008
3Alemtuzumab (Campath)FDA Link
01/2015 - 08/2003
3Complement System Proteins (Complement)IBA
09/2012 - 10/2008
3Vitamin DFDA LinkGeneric
07/2012 - 09/2010
3Interleukin-12 (IL 12)IBA
04/2012 - 01/2002
3Interleukin-10 (Interleukin 10)IBA
03/2012 - 10/2009
3Interleukin-6 (Interleukin 6)IBA
11/2011 - 10/2003
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2010 - 05/2003
3Phosphotransferases (Kinase)IBA
08/2008 - 05/2003
2Immune Checkpoint InhibitorsIBA
01/2021 - 03/2016
2carboxyl radical (COO-)IBA
01/2019 - 11/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2019 - 10/2003
2Messenger RNA (mRNA)IBA
01/2019 - 08/2005
2pomalidomideIBA
11/2018 - 06/2012

Therapy/Procedure

83Therapeutics
01/2022 - 01/2002
25Radioimmunotherapy
01/2017 - 02/2002
23Drug Therapy (Chemotherapy)
01/2022 - 06/2002
11Stem Cell Transplantation
01/2022 - 12/2002
6Radiotherapy
10/2016 - 12/2003
5Immunotherapy
01/2021 - 05/2002
5Aftercare (After-Treatment)
09/2008 - 04/2003
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
04/2006 - 05/2004
2Precision Medicine
01/2019 - 01/2018